(HealthDay)—California researchers are testing whether an oral vaccine offers similar or better protection than current COVID-19 shots.
Covax backs AstraZeneca as vaccines reach 100 territories
Covax backed the AstraZeneca jab on Thursday as the scheme celebrated shipping coronavirus vaccine doses to 100 different territories around the world, despite delays dogging deliveries.
Evolution of outcomes for patients hospitalized during the COVID pandemic
As SARS-CoV-2 continues to spread in France, a thorough characterization of hospital care needs and of the trajectories of hospital patients, as well as how they have changed over time, is essential to support planning. This led scientists from the Mathematical Modeling of Infectious Diseases Unit at the Institut Pasteur and the University of Cambridge …
Low-dose CT for right colonic diverticulitis an alternate diagnosis of appendicitis
According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), IV contrast-enhanced 2-millisievert CT (2-mSv CT) is comparable to conventional-dose CT (CDCT) for the diagnosis of right colonic diverticulitis.
Light shed on the coordination of neural stem cell activation
In all adult vertebrates, neural stem cells can be recruited to produce new neurons in the brain. However, little is known about these so-called ‘activation’ processes.
Artificial Intelligence could ‘crack the language of cancer and Alzheimer’s’
Powerful algorithms used by Netflix, Amazon and Facebook can ‘predict’ the biological language of cancer and neurodegenerative diseases like Alzheimer’s, scientists have found.
Children and SARS-CoV-2: More infections than reported cases during second wave in Germany
The prevalence of SARS-CoV-2 infections in preschool and school children is an important benchmark for deciding whether to open kindergartens and schools. The screening study ‘Fr1da’ led by Anette-Gabriele Ziegler tests children in Bavaria for an early stage of type 1 diabetes. These tests include the collection of blood samples. In response to the COVID-19 …
A new agent for brain diseases: mRNA
A lack of oxygen to brain tissue—known as ischemia—leads to the death of neurons, which results in stroke. Despite considerable research, there are currently no treatments that successfully prevent neuronal death. Now, Tokyo Medical and Dental University (TMDU) researchers have reported a way of delivering mRNA to produce a therapeutic protein that protects neurons. Their …
Cycling study transforms heart health of dialysis patients
Cycling at moderate intensity during dialysis could drastically improve the heart health of patients with kidney failure and result in significant savings for the NHS, according to new research by the University of Leicester supported by the charity Kidney Research UK and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre.
Chronic sinus inflammation appears to alter brain activity
The millions of people who have chronic sinusitis deal not only with stuffy noses and headaches, they also commonly struggle to focus, and experience depression and other symptoms that implicate the brain’s involvement in their illness.